The DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index.
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Open accessAbstract
Background The long-term health consequences of COVID-19 remain largely unclear. The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.Methods We did an ambidirectional cohort study of patients with confirmed COVID-19 who had been discharged from Jin Yin-tan Hospital (Wuhan, China) between Jan 7, 2020, and May 29, 2020. Patients who died before follow-up, patients for whom follow-up would be difficult because of psychotic disorders, dementia, or re-admission to hospital, those who were unable to move freely due to concomitant osteoarthropathy or immobile before or after discharge due to diseases such as stroke or pulmonary embolism, those who declined to participate, those who could not be contacted, and those living outside of Wuhan or in nursing or welfare homes were all excluded. All patients were interviewed with a series of questionnaires for evaluation of symptoms and health-related quality of life, underwent physical examinations and a 6-min walking test, and received blood tests. A stratified sampling procedure was used to sample patients according to their highest seven-category scale during their hospital stay as 3, 4, and 5-6, to receive pulmonary function test, high resolution CT of the chest, and ultrasonography. Enrolled patients who had participated in the Lopinavir Trial for Suppression of SARS-CoV-2 in China received severe acute respiratory syndrome coronavirus 2 antibody tests. Multivariable adjusted linear or logistic regression models were used to evaluate the association between disease severity and long-term health consequences.Findings In total, 1733 of 2469 discharged patients with COVID-19 were enrolled after 736 were excluded. Patients had a median age of 57·0 (IQR 47·0-65·0) years and 897 (52%) were men. The follow-up study was done from June 16, to Sept 3, 2020, and the median follow-up time after symptom onset was 186·0 (175·0-199·0) days. Fatigue or muscle weakness (63%, 1038 of 1655) and sleep difficulties (26%, 437 of 1655) were the most common symptoms. Anxiety or depression was reported among 23% (367 of 1617) of patients. The proportions of median 6-min walking distance less than the lower limit of the normal range were 24% for those at severity scale 3, 22% for severity scale 4, and 29% for severity scale 5-6. The corresponding proportions of patients with diffusion impairment were 22% for severity scale 3, 29% for scale 4, and 56% for scale 5-6, and median CT scores were 3·0 (IQR 2·0-5·0) for severity scale 3, 4·0 (3·0-5·0) for scale 4, and 5·0 (4·0-6·0) for scale 5-6. After multivariable adjustment, patients showed an odds ratio (OR) 1·61 (95% CI 0·80-3·25) for scale 4 versus scale 3 and 4·60 (1·85-11·48) for scale 5-6 versus scale 3 for diffusion impairment; OR 0·88 (0·66-1·17) for scale 4 versus scale 3 and OR 1·77 (1·05-2·97) for scale 5-6 versus scale 3 for anxiety or depression, and OR 0·74 (0·58-0·96) for scale 4 versus scale 3 and 2·69 (1·46-4·96) for scale 5-6 versus scale 3 for fatigue or muscle weakness. Of 94 patients with blood antibodies tested at follow-up, the seropositivity (96·2% vs 58·5%) and median titres (19·0 vs 10·0) of the neutralising antibodies were significantly lower compared with at the acute phase. 107 of 822 participants without acute kidney injury and with estimated glomerular filtration rate (eGFR) 90 mL/min per 1·73 m 2 or more at acute phase had eGFR less than 90 mL/min per 1·73 m 2 at follow-up.Interpretation At 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, and are the main target population for intervention of long-term recovery.Funding National Natural Science Foundation of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Key Research and Development Program of China, Major Projects of National Science and Technology on New Drug Creation and Development of Pulmonary Tuberculosis, and Peking Union Medical College Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These mental health symptoms persist even after the acute stage of the disease.”
From Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol (2023) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Further, severe lung complications from COVID-19 may have persisting limitations to respiratory function and gas exchange; this group of patients, therefore, should be the primary target population for the intervention of long-term recovery.”
From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Abdominal chest imaging, and severe impairment to pulmonary diffusion capacities was reported in COVID-19 patients recovered from severe illness [32].”
From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [32]
In the citing paper
“Nevertheless, what emerges from preliminary data is the negative impact of long COVID on quality of life and its effects on patient work ability and social relationships [1,4,19].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“These symptoms can endure up to 6–7 months and even longer [[1], [2], [3], [4], [5]].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“Advanced age was associated with ongoing fatigue and musculoskeletal pain, or impairment in pulmonary functions, reflecting a decline in organ function and a slower ability to recover [1,16].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“Literature data are not equivocal about the association between females and long COVID: some preliminary studies have shown an increased prevalence of fatigue [24] or other symptoms among women [1,5,13,16], while in other studies no gender association was found [4,[18], [19], [20]].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Standardization of Spirometry, 1994 Update. American Thoracic Society
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,605
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,258
Self-citationWiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)
Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R. L., Yang, L., et al. (2020) · Radiology · doi:10.1148/radiol.2020200370 · Cited by 2,915
Self-citation
Cited by
Sorted by citations
Items 501–600 of 1,004
Neurological post‐acute sequelae of SARS‐CoV ‐2 infection
Takao, M., & Ohira, M. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13481 · Cited by 66
DMW - Deutsche Medizinische Wochenschrift
Medizin, D. G. F. I., & Ärzte, G. D. N. U. (2026) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-00000011 · Cited by 64
Measures of physical performance in COVID-19 patients: a mapping review
Simonelli, C., Paneroni, M., Vitacca, M., & Ambrosino, N. (2021) · Pulmonology · doi:10.1016/j.pulmoe.2021.06.005 · Cited by 63
Jones, R. C. M., Davis, A., Stanley, B. O. C., Julious, S. A., Ryan, D. P., Jackson, D. J., Halpin, D. M. G., Hickman, K., Pinnock, H., Quint, J. K., et al. (2021) · Pragmatic and Observational Research · doi:10.2147/por.s316186 · Cited by 67
Korompoki, E., Gavriatopoulou, M., Fotiou, D., Ntanasis‐Stathopoulos, I., Dimopoulos, M. A., & Terpos, E. (2021) · American Journal of Hematology · doi:10.1002/ajh.26384 · Cited by 64
Titze‐de‐Almeida, R., da Cunha, T. R., Silva, L. D. D. S., Ferreira, C. S., Silva, C. P., Ribeiro, A. P., Júnior, A. D. C. M. S., Brandão, P. R. D. P., Silva, A. P. B., da Rocha, M. C. O., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07065-3 · Cited by 63
Tsuchida, T., Hirose, M., Inoue, Y., Kunishima, H., Otsubo, T., & Matsuda, T. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27689 · Cited by 65
Giron, L. B., Peluso, M. J., Ding, J., Kenny, G., Zilberstein, N., Koshy, J., Hong, K. Y., Rasmussen, H. E., Miller, G. E., Bishehsari, F., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160989 · Cited by 67
Epidemiology and Clinical Presentation of COVID-19 in Older Adults
Abul, Y., Leeder, C., & Gravenstein, S. (2022) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2025.09.007 · Cited by 69
Naik, H., Shao, S., Tran, K. C., Wong, A. W., Russell, J. A., Khor, E., Nacul, L., Mckay, R. J., Carlsten, C., Ryerson, C. J., et al. (2022) · Health and Quality of Life Outcomes · doi:10.1186/s12955-022-02082-x · Cited by 63
Gu, X., Wang, S., Zhang, W., Li, C., Guo, L., Wang, Z., Li, H., Zhang, H., Zhou, Y., Liang, W., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104851 · Cited by 68
Self-citationSwiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID
Funke-Chambour, M., Bridevaux, P., Clarenbach, C. F., Soccal, P. M., Nicod, L. P., von Garnier, C., & on behalf of the Swiss COVID Lung Study Group and the Swiss Society of Pulmonology (2021) · Respiration · doi:10.1159/000517255 · Cited by 64
Protracted respiratory findings in children post‐SARS‐CoV‐2 infection
Dobkin, S. L., Collaco, J. M., & McGrath‐Morrow, S. A. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.25671 · Cited by 63
Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research
Caronna, E., & Pozo‐Rosich, P. (2021) · Current Pain and Headache Reports · doi:10.1007/s11916-021-00987-8 · Cited by 62
Time to Sleep?—A Review of the Impact of the COVID-19 Pandemic on Sleep and Mental Health
Neculicioiu, V. S., Colosi, I. A., Costache, C. A., Sevastre-Berghian, A., & Clichici, S. V. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19063497 · Cited by 68
SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters
Qiao, W., Lau, H. E., Xie, H., Poon, V. K., Chan, C. C., Chu, H., Yuan, S., Yuen, T. T., Chik, K. K., Tsang, J. O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30195-w · Cited by 62
Colosio, M., Brocca, L., Gatti, M. F., Neri, M., Crea, E., Cadile, F., Canepari, M., Pellegrino, M. A., Polla, B., Porcelli, S., et al. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00158.2023 · Cited by 65
Shen, Q., Joyce, E. E., Ebrahimi, O. V., Didriksen, M., Lovik, A., Sævarsdóttir, K. S., Magnúsdóttir, I., Mikkelsen, D. H., Unnarsdóttir, A. B., Hauksdóttir, A., et al. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100756 · Cited by 62
Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approach
Silva, C. C., Bichara, C. N. C., Carneiro, F. R. O., Palácios, V. R. D. C. M., van den Berg, A. V. S., Quaresma, J. A. S., & Falcão, L. F. M. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2355 · Cited by 56
Microbiota and COVID-19: Long-term and complex influencing factors
Gang, J., Wang, H., Xue, X., & Zhang, S. J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.963488 · Cited by 62
Exercise Is Medicine for Immune Function: Implication for COVID-19
Nieman, D. C. (2021) · Current Sports Medicine Reports · doi:10.1249/jsr.0000000000000867 · Cited by 64
Buske, C., Dreyling, M. H., Álvarez‐Larrán, A., Apperley, J. F., Arcaini, L., Besson, C., Bullinger, L., Corradini, P., Porta, M. G. D., Dimopoulos, M. A., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100403 · Cited by 61
Han, J. H., Womack, K. N., Tenforde, M. W., Files, D. C., Gibbs, K. W., Shapiro, N. I., Prekker, M. E., Erickson, H. L., Steingrub, J. S., Qadir, N., et al. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12980 · Cited by 65
Long-Term Mortality Following COVID-19 Infection: A National Cohort Study From Estonia
Uusküla, A., Jürgenson, T., Pisarev, H., Kolde, R., Meister, T., Tisler, A., Suija, K., Kalda, R., Piirsoo, M., & Fischer, K. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100394 · Cited by 60
Wahlgren, C., Divanoglou, A., Larsson, M., Nilsson, E., Balkhed, Å. Ö., Niward, K., Thornberg, U. B., Gudmundsson, E. L., & Levi, R. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101219 · Cited by 60
Feasibility of Virtual Reality Exercises at Home for Post–COVID-19 Condition: Cohort Study
Groenveld, T. D., Achttien, R. J., Smits, M., de Vries, M., van Heerde, R., Staal, J. B., van Goor, H., & COVID Rehab Group (2022) · JMIR Rehabilitation and Assistive Technologies · doi:10.2196/36836 · Cited by 60
Patel, M. A., Knauer, M. J., Nicholson, M., Daley, M., Nynatten, L. R. V., Cepinskas, G., & Fraser, D. D. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00610-z · Cited by 65
Leite, V. F., Rampim, D. B., Jorge, V. C., de Lima, M. D. C. C., Cezarino, L. G., da Rocha, C. N., & Ésper, R. B. (2021) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2021.03.001 · Cited by 59
Barazzoni, R., Bischoff, S. C., Busetto, L., Cederholm, T., Chourdakis, M., Cuerda, C., Delzenne, N. M., Genton, L., Schneider, S. M., Singer, P., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.05.006 · Cited by 64
COVID‐19 and immunothrombosis: emerging understanding and clinical management
Shaw, R., Bradbury, C. A., Abrams, S. T., Wang, G., & Toh, C. (2021) · British Journal of Haematology · doi:10.1111/bjh.17664 · Cited by 60
Self-citationDarcis, G., Bouquegneau, A., Maes, N., Thys, M., Henket, M. A., Labye, F., Rousseau, A., Canivet, P., Desir, C., Calmès, D., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.07.016 · Cited by 60
Kyzar, E. J., Purpura, L. J., Shah, J., Cantos, A., Nordvig, A. S., & Yin, M. T. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100315 · Cited by 61
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
Bellucci, G., Rinaldi, V., Buscarinu, M. C., Reniè, R., Bigi, R., Pellicciari, G., Morena, E., Romano, C., Marrone, A., Mechelli, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.755333 · Cited by 59
Arutyunov, G. P., Tarlovskaya, E. I., Arutyunov, A. G., Belenkov, Y. N., Конради, А. О., Lopatin, Y. M., Rebrov, A. P., Tereshchenko, S. N., Chesnikova, A. I., Hayrapetyan, H. G., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4708 · Cited by 59
Gordon, M. N., Heneka, M. T., Page, L. M. L., Limberger, C., Morgan, D., Tenner, A. J., Terrando, N., Willette, A. A., & Willette, S. A. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12488 · Cited by 59
Respiratory muscle dysfunction in long-COVID patients
Hennigs, J. K., Huwe, M., Hennigs, A., Oqueka, T., Simon, M., Harbaum, L., Körbelin, J., Schmiedel, S., Wiesch, J. S. Z., Addo, M. M., et al. (2022) · Infection · doi:10.1007/s15010-022-01840-9 · Cited by 61
Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism
Luijten, D., de Jong, C. M. M., Ninaber, M. K., Spruit, M. A., Huisman, M. V., & Klok, F. A. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1749659 · Cited by 61
Post COVID-19 condition of the Omicron variant of SARS-CoV-2
Morioka, S., Tsuzuki, S., Suzuki, M., Terada, M., Akashi, M., Osanai, Y., Kuge, C., Sanada, M., Tanaka, K., Maruki, T., et al. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.08.007 · Cited by 61
Abdallah, S. B., Mhalla, Y., Trabelsi, I., Sekma, A., Youssef, R., Ali, K. B. H., Soltane, H. B., Yacoubi, H., Msolli, M. A., Stambouli, N., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac807 · Cited by 59
Matsumoto, C., Shibata, S., Kishi, T., Morimoto, S., Mogi, M., Yamamoto, K. I., Kobayashi, K., Tanaka, M., Asayama, K., Yamamoto, E., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-01145-2 · Cited by 61
Rosa, R. G., Cavalcanti, A. B., Azevedo, L. C. P., Veiga, V. C., de Souza, D., dos Santos, R. D. R. M., Schardosim, R. F. D. C., Rech, G. S., Trott, G., Schneider, D., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-022-06953-1 · Cited by 59
Understanding COVID-19 in children: immune determinants and post-infection conditions
Rotulo, G. A., & Palma, P. (2023) · Pediatric Research · doi:10.1038/s41390-023-02549-7 · Cited by 60
Choi, Y., Kim, H. J., Park, J., Lee, M., Kim, S. Y., Koyanagi, A., Smith, L., Kim, M. S., Rahmati, M., Lee, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48825-w · Cited by 60
Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia
Liu, B. C., Jayasundara, D., Pye, V., Dobbins, T., Dore, G. J., Matthews, G. V., Kaldor, J. M., & Spokes, P. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100193 · Cited by 60
Martin, I., Braem, F., Baudet, L., Poncin, W., Fizaine, S., Nana, F. A., Froidure, A., Pilette, C., Liistro, G., Greef, J. D., et al. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106438 · Cited by 58
Arnold, D., Milne, A., Samms, E., Stadon, L. J., Maskell, N. A., & Hamilton, F. (2021) · Annals of Internal Medicine · doi:10.7326/m21-1976 · Cited by 58
Caronna, E., Alpuente, A., Torres‐Ferrús, M., & Pozo‐Rosich, P. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14197 · Cited by 58
de Oliveira, J. F., de Ávila, R. E., de Oliveira, N. R., Sampaio, N. D. C. S., Botelho, M. D. L., Gonçalves, F. A., Neto, C. J. F., Milagres, A. C. D. A., Gomes, T. C. C., Pereira, T. L., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.07.063 · Cited by 64
Ozonoff, A., Jayavelu, N. D., Liu, S., Melamed, E., Milliren, C. E., Qi, J., Geng, L. N., McComsey, G. A., Cairns, C. B., Baden, L. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44090-5 · Cited by 62
Epidemiologic Features of Recovery From SARS-CoV-2 Infection
Oelsner, E. C., Sun, Y., Balte, P., Allen, N. B., Andrews, H., Carson, A. P., Cole, S. A., Coresh, J., Couper, D. J., Cushman, M., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.17440 · Cited by 58
Infection and chronic disease activate a systemic brain-muscle signaling axis
Yang, S., Tian, M., Dai, Y., Wang, R., Yamada, S., Feng, S., Wang, Y., Chhangani, D., Ou, T., Li, W., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adm7908 · Cited by 58
Self-citationA longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae
LaVergne, S. M., Stromberg, S., Baxter, B. A., Webb, T. L., Dutt, T. S., Berry, K., Tipton, M., Haberman, J., Massey, B. R., McFann, K., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06359-2 · Cited by 58
Husaini, A. M., Jan, K. N., & Wani, G. A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07068 · Cited by 57
Scheiber, B., Spiegl, C., Wiederin, C., Schifferegger, E., & Schiefermeier-Mach, N. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168730 · Cited by 60
Eight Weeks Unsupervised Pulmonary Rehabilitation in Previously Hospitalized of SARS-CoV-2 Infection
Stavrou, V. T., Tourlakopoulos, K. N., Vavougios, G. D., Papayianni, E., Kiribesi, K., Maggoutas, S., Nikolaidis, K., Fradelos, Ε. C., Dimeas, I. E., Daniil, Z. D., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080806 · Cited by 62
Bohnacker, S., Hartung, F., Henkel, F. D. R., Quaranta, A., Kolmert, J., Priller, A., Ud‐Dean, M., Giglberger, J., Kugler, L. M., Pechtold, L., et al. (2022) · Mucosal Immunology · doi:10.1038/s41385-021-00482-8 · Cited by 60
Rebelatto, C. L. K., Senegaglia, A. C., Franck, C. L., Daga, D. R., Shigunov, P., Stimamiglio, M. A., Marsaro, D. B., Schaidt, B., Micosky, A., de Azambuja, A. P., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02796-1 · Cited by 56
SARS-CoV-2 Infection and Lung Regeneration
Zhao, F., Ma, Q., Yue, Q., & Chen, H. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00188-21 · Cited by 58
Capin, J. J., Jolley, S. E., Morrow, M., Connors, M., Hare, K., MaWhinney, S., Nordon‐Craft, A., Rauzi, M. R., Flynn, S. M., Stevens‐Lapsley, J. E., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061285 · Cited by 63
Joseph, P., Singh, I., Oliveira, R. K. F., Capone, C. A., Mullen, M. P., Cook, D. B., Stovall, M. C., Squires, J., Madsen, K., Waxman, A. B., et al. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.03.049 · Cited by 57
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
Patel, J., Bass, D., Beishuizen, A., Ruiz, X. B., Boughanmi, H., Cahn, A. P., Colombo, H. R., Criner, G. J., Davy, K., de Miguel‐Díez, J., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01870-2021 · Cited by 59
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study
Faverio, P., Luppi, F., Rebora, P., Busnelli, S., Stainer, A., Catalano, M., Parachini, L., Monzani, A., Galimberti, S., Bini, F., et al. (2021) · Respiration · doi:10.1159/000518141 · Cited by 58
Addressing the Long COVID Crisis: Integrative Health and Long COVID
Roth, A. R., Chan, P. S., & Jonas, W. B. (2021) · Global Advances in Health and Medicine · doi:10.1177/21649561211056597 · Cited by 59
Betschart, M., Rezek, S. A., Unger, I., Ott, N., Beyer, S., Böni, A., Gisi, D., Shannon, H., Spruit, M. A., & Sieber, C. C. (2021) · Swiss Medical Weekly · doi:10.4414/smw.2021.w30072 · Cited by 56
Zangrillo, A., Belletti, A., Palumbo, D., Calvi, M. R., Guzzo, F., Fominskiy, E. V., Ortalda, A., Nardelli, P., Ripa, M., Redaelli, M. B., et al. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.11.032 · Cited by 57
Konopka, K. E., Perry, W., Huang, T., Farver, C. F., & Myers, J. L. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101209 · Cited by 56
The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection
dos Santos, P. K., Sigoli, E., Bragança, L. J. G., & Cornachione, A. S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.813924 · Cited by 57
Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection
Mina, Y., Enose‐Akahata, Y., Hammoud, D. A., Videckis, A. J., Narpala, S., O’Connell, S. E., Carroll, R., Lin, B. C., McMahan, C. C., Nair, G., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200097 · Cited by 60
Longobardi, I., Goessler, K. F., Júnior, G. N. D. O., do Prado, D. M. L., Santos, J. V. P., Meletti, M. M., ANDRADE, D. C. O. D., Gil, S. D. S., Boza, J. A. S. D. O., Lima, F. R., et al. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-106681 · Cited by 57
Raman, B., McCracken, C., Cassar, M. P., Moss, A. J., Finnigan, L., Samat, A. H. A., Ogbole, G. I., Tunnicliffe, E. M., Alfaro‐Almagro, F., Menke, R., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00262-x · Cited by 56
Townsend, L., Dyer, A. H., Naughton, A., Kiersey, R., Holden, D., Gardiner, M., Dowds, J., O’Brien, K., Bannan, C., Nadarajan, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676932 · Cited by 58
Yusuf, F., Fahriani, M., Mamada, S. S., Frediansyah, A., Abubakar, A., Maghfirah, D., Fajar, J. K., Maliga, H. A., Ilmawan, M., Emran, T. B., et al. (2021) · F1000Research · doi:10.12688/f1000research.52216.1 · Cited by 55
Gautam, N., Madathil, S. C., Tahani, N., Bolton, S., Parekh, D., Stockley, J. A., Goyal, S., Qureshi, H., Yasmin, S., Cooper, B. G., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab341 · Cited by 59
Beck, K., Vincent, A., Becker, C., Keller, A., Cam, H., Schaefert, R., Reinhardt, T., Sutter, R., Tisljar, K., Bassetti, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250590 · Cited by 57
A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 58
Zayet, S., Zahra, H., Royer, P.-Y., Tipirdamaz, C., Mercier, J., Gendrin, V., Lepiller, Q., Marty-Quinternet, S., Osman, M., Belfeki, N., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9081719 · Cited by 55
Hellemons, M. E., Huijts, S., Bek, L. M., Berentschot, J. C., Nakshbandi, G., Schurink, C. A. M., Vlake, J. H., van Genderen, M. E., van Bommel, J., Gommers, D., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202103-340oc · Cited by 56
Covid‐19 sequelae in working age patients: A systematic review
d’Ettorre, G., Cacciola, E. G., Santinelli, L., Girolamo, G. D., Spagnolello, O., Russo, A., Tarsitani, L., Ciccozzi, M., Mastroianni, C. M., d’Ettorre, G., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27399 · Cited by 55
Characteristics of Post-ICU and Post-COVID Recovery Clinics in 29 U.S. Health Systems
Danesh, V. C., Boehm, L. M., Eaton, T. L., Arroliga, A. C., Mayer, K. P., Kesler, S. R., Bakhru, R. N., Baram, M., Bellinghausen, A. L., Biehl, M., et al. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000658 · Cited by 55
Margalit, I., Yelin, D., Sagi, M., Rahat, M. M., Sheena, L., Mizrahi, N., Gordin, Y., Agmon, H., Karny-Epstein, N., Atamna, A., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac283 · Cited by 55
Chommeloux, J., Valentin, S., Winiszewski, H., Adda, M., de Chambrun, M. P., Moyon, Q., Mathian, A., Capellier, G., Guervilly, C., Lévy, B., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202206-1145oc · Cited by 55
Al‐Hakeim, H. K., Al-Rubaye, H. T., Almulla, A. F., Al-Hadrawi, D. S., & Maes, M. H. J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020511 · Cited by 57
Rapid Design and Implementation of Post-COVID-19 Clinics
Santhosh, L., Block, B. L., Kim, S. Y., Raju, S., Shah, R., Thakur, N., Brigham, E. P., & Parker, A. M. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.03.044 · Cited by 55
Frija‐Masson, J., Debray, M., Boussouar, S., Khalil, A., Bancal, C., Motiejūnaitė, J., Galarza-Jimenez, M.-A., Benzaquen, H., Penaud, D., Laveneziana, P., et al. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106435 · Cited by 54
Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery
Yan, X., Huang, H., Wang, C., Jin, Z., Zhang, Z., He, J., Yin, S., Fan, M., Huang, J., Chen, F., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.05.034 · Cited by 54
Self-citationFrontera, J. A., Lewis, A. K., Melmed, K. R., Lin, J., Kondziella, D., Helbok, R., Yaghi, S. R., Meropol, S. B., Wısnıewskı, T., Balcer, L. J., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690383 · Cited by 59
Gu, X., Huang, L., Cui, D., Wang, Y., Wang, Y., Xu, J., Shang, L., Fan, G., & Cao, B. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103817 · Cited by 56
Self-citationHealth Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection
Kingery, J. R., Safford, M. M., Martin, P., Lau, J. D., Rajan, M., Wehmeyer, G. T., Li, H. A., Alshak, M. N., Jabri, A., Kofman, A., et al. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07379-z · Cited by 54
Burden of Prostate Cancer in China, 1990–2019: Findings From the 2019 Global Burden of Disease Study
Wang, F., Wang, C., Xia, H., Lin, Y., Zhang, D., Yin, P., & Yao, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.853623 · Cited by 54
Self-citationHaider, S., Janowski, A. J., Lesnak, J. B., Hayashi, K., Dailey, D. L., Chimenti, R. L., Frey‐Law, L., Sluka, K. A., & Berardi, G. (2022) · Pain · doi:10.1097/j.pain.0000000000002711 · Cited by 61
Wu, Q., Ailshire, J., & Crimmins, E. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-15727-0 · Cited by 55
Immunologic phenotype of patients with long-COVID syndrome of 1-year duration
García‐Abellán, J., Fernández‐González, M., Padilla, S., García, J. A., Agulló, V., Lozano, V., Ena, N., García-Sánchez, L., Gutiérrez, F., & Masiá, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.920627 · Cited by 55
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Arish, M., Qian, W. G., Narasimhan, H., & Sun, J. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28122 · Cited by 55
Persistent symptoms among post‐COVID ‐19 survivors: A systematic review and meta‐analysis
Rochmawati, E., Iskandar, A. C., & Kamilah, F. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.16471 · Cited by 63
Multidisciplinary Center Care for Long COVID Syndrome–A Retrospective Cohort Study
Bailey, J. I., Lavelle, B., Miller, J. L., Jimenez, M., Lim, P. H., Orban, Z. S., Clark, J. R., TOMAR, R., Ludwig, A., Ali, S. T., et al. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2023.05.002 · Cited by 55
Al‐Hakeim, H. K., Abed, A. K., Moustafa, S. R., Almulla, A. F., & Maes, M. H. J. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1194769 · Cited by 54
Theoharides, T. C., Twahir, A., & Kempuraj, D. (2023) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2023.10.032 · Cited by 58
Impact of the COVID-19 pandemic on the care of cancer patients in Spain
Amador, M. L., Matías‐Guiu, X., Sancho, G., Contreras, J., Montero, J. C. D. L. T., Saiz, A. P., Garrido, P., García‐Sánz, R., Rodríguez-Lescure, Á., & Paz-Ares, L. G. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100157 · Cited by 54
Clinical Management of COVID-19 Patients – An Update
Mølhave, M., Agergaard, J., & Wejse, C. M. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2021.06.004 · Cited by 55
Zhou, Z., Luo, H., Liu, J., Du, Y., Zhao, W., Zhou, X.-L., Zeng, M., Yang, D., Xie, X., Huang, S., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.327361 · Cited by 54
Self-citation
Metadata
- Authors
- Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., Luo, J., Huang, Z., Tu, S., Zhao, Y., Chen, L., Xu, D., Li, Y., Li, C., Peng, L., Li, Y., Xie, W., Cui, D., Shang, L., Fan, G., Xu, J., Wang, G., Wang, Y., Zhong, J., Wang, C., Wang, J., Zhang, D., & Cao, B.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Capital Medical University (CN)
- China-Japan Friendship Hospital (CN)
- Jinyintan Hospital (CN)
- Peking University (CN)
- Harbin Medical University (CN)
- Beijing University of Chinese Medicine (CN)
- Tsinghua University (CN)
- Corresponding author
- Cao, Bin
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 397
- Issue
- 10270
- Pages
- 220-232
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC7833295
- OpenAlex
- W3120387768
- Cited by
- 4,084
- References
- 41
- Citations by year
- 2026: 67 · 2025: 180 · 2024: 510 · 2023: 934 · 2022: 1300 · 2021: 1088
- FWCI
- 458.37
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science and Technology Major Project (2020ZX09201001)
- Chinese Academy of Medical Sciences (2020-I2M-CoV19\u2013005)
- National Natural Science Foundation of China (82041011/H0104)
- National Key Research and Development Program of China (2018YFC1200102)
- China-Japan Friendship Hospital
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 pandemic, long-term health effects, long COVID, fatigue, muscle weakness, sleep disorders, anxiety, depression, disease severity, health-related quality of life, physical function, lung function, SARS-CoV-2, retraction, Wuhan, post-discharge follow-up, risk factors, lopinavir
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Serological Testing, Post-Acute COVID-19 Syndrome, Aged, China, Fatigue, Female, Humans, Length of Stay, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Sleep Wake Disorders, Cohort Studies, Comorbidity, Muscle Weakness, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
